Myeloproliferative Neoplasms (MPNs) Treatment Team - Dana-Farber Cancer Institute | Boston, MA

Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Myeloproliferative Neoplasms (MPNs) Treatment Team

Your treatment team includes oncologists, physician assistants (PAs), nurse practitioners, clinical and research nurses, hematopathologists, pharmacists, and others who are experienced in caring for patients with all forms of MPN. In addition, laboratory investigators, clinical care coordinators, clinical social workers, and nutritionists will be part of your care team.

Our providers work together across a range of specialty areas to coordinate fully integrated, personalized care from your initial diagnosis through long-term follow up.

New Patient Appointments
877-442-3324
Make Appointment Online

Medical Oncology

Gregory A. Abel, MD, MPH

Director, Older Adult Hematologic Malignancy Program

Evan C. Chen, MD

Instructor in Medicine, Harvard Medical School

Daniel J. DeAngelo, MD, PhD

Chief, Division of Leukemia

James A. DeCaprio, MD

Physician

Jacqueline S. Garcia, MD

Physician

James D. Griffin, MD

Professor of Medicine, Harvard Medical School

Andrew A. Lane, MD, PhD

Director, Blastic Plasmacytoid Dendritic Cell Neoplasm Center

Anthony G. Letai, MD, PhD

Physician

R. Coleman Lindsley, MD, PhD

Physician

Marlise R. Luskin, MD, MSCE

Associate Program Director, Dana-Farber/Mass General Brigham Hematology/Oncology Fellowship Program

Ann Mullally, MD

Physician

Christopher R. Reilly, MD

Donor Services Medical Director

Maximilian Stahl, MD

Physician

Richard M. Stone, MD

Chief of Staff

Zuzana Tothova, MD, PhD

Physician

Rahul S. Vedula, MD

Physician

Martha Wadleigh, MD

Medical Director, Inpatient Oncology

Lachelle D. Weeks, MD, PhD

Physician

Eric S. Winer, MD

Clinical Director, Adult Leukemia